NCT02022371View on ClinicalTrials.gov

Prostate Cancer Genomic Heterogeneity

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
PROSTATE CANCER
Interventions
PROCEDURE

Targeted biopsies of the prostate

Multiple biopsies from a MRI lesion for analysis of intratumour heterogeneity

Trial Locations (1)

NW1 2BU

University College London Hospitals, London

All Listed Sponsors
lead

University College London Hospitals

OTHER

NCT02022371 - Prostate Cancer Genomic Heterogeneity | Biotech Hunter | Biotech Hunter